The Lancet Psychiatry and MQ, a mental health research charity, convened a panel of experts during Q1 2020 to consider the research priorities arising from the COVID-19 pandemic. This group evolved into an interdisciplinary, global, three-year standing commission including people with lived experience to report on the extent to which research priorities were met, to examine the results and implications of the emergent research, and to make recommendations for future research regarding COVID and other emergent pandemic emergencies.
This session includes the conclusions in the public health, policy implications, and the neuropsychiatric sequelae of SARS-CoV-2 infection.
Learning objectives
In this session you will:
- Gain understanding on the balance between quality of evidence and strength of conclusions at different stages of disaster response
- Learn about the findings regarding mental health effects of the COVID-19 pandemic on mental health
- Reflect on personal and organisational responses to public and clinical mental health care during the pandemic from the point of view of future planning.
Speakers
Chair: Professor Peter B. Jones, University of Cambridge, Cambridge and Ms Sophia David, The Lancet Psychiatry
Professor Etheldreda Nakimuli-Mpungu, Makerere University, Makerere, Uganda
Ms Alexandra M. Schuster, University of Cambridge, Cambridge
Dr Maxime Taquet, University of Oxford, Oxford
Availability
This webinar is part of the Congress webinar 2025 package. If you attended all four days of Congress, you will have access to these as part of your Congress package. Otherwise the Congress webinar 2025 package can be purchased below.
